| Juan Edgar Lerma, MD | |
|
2850 W. 95th St, Mary Potter Bldg St. 11, Evergreen Park, IL 60805-2727 | |
| (708) 499-2243 | |
| (708) 424-1799 |
| Full Name | Juan Edgar Lerma |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 33 Years |
| Location | 2850 W. 95th St, Evergreen Park, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841279981 | NPI | - | NPPES |
| 036097893 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036097893 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concerto Dialysis | Crestwood, IL | Dialysis facility |
| Fmc - Midway Dialysis | Chicago, IL | Dialysis facility |
| Fmc - Burbank | Burbank, IL | Dialysis facility |
| Fresenius Kidney Care Chicagoland Llc | Evergreen park, IL | Dialysis facility |
| Affiliated Dialysis Centers | Oak park, IL | Dialysis facility |
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Nephrology Sc | 9133023963 | 51 |
News Archive
At the Association for Glycogen Storage Disease's 41st Annual Conference, Dr. David Weinstein of UConn School of Medicine and Connecticut Children's presented his groundbreaking, one-year clinical trial results for the novel gene therapy treatment for glycogen storage disease.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
"The Pacific Islands are making steady progress on reducing child mortality, but most are struggling to eradicate poverty and generate employment for young and rapidly growing populations," Inter Press Service reports in an article examining how 10 of 14 nations in the region are on track to meet the Millennium Development Goal (MDG) on child mortality.
Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration caused by old age and diseases such as muscular dystrophy.
Peripheral nervous system tumors are one of the most common types of childhood tumors. While some of these tumors, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment.
› Verified 6 days ago
| Entity Name | Associates In Nephrology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184694259 PECOS PAC ID: 9133023963 Enrollment ID: O20031124000308 |
News Archive
At the Association for Glycogen Storage Disease's 41st Annual Conference, Dr. David Weinstein of UConn School of Medicine and Connecticut Children's presented his groundbreaking, one-year clinical trial results for the novel gene therapy treatment for glycogen storage disease.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
"The Pacific Islands are making steady progress on reducing child mortality, but most are struggling to eradicate poverty and generate employment for young and rapidly growing populations," Inter Press Service reports in an article examining how 10 of 14 nations in the region are on track to meet the Millennium Development Goal (MDG) on child mortality.
Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration caused by old age and diseases such as muscular dystrophy.
Peripheral nervous system tumors are one of the most common types of childhood tumors. While some of these tumors, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment.
› Verified 6 days ago
| Entity Name | Insight Chicago Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881261006 PECOS PAC ID: 2860894706 Enrollment ID: O20210714002059 |
News Archive
At the Association for Glycogen Storage Disease's 41st Annual Conference, Dr. David Weinstein of UConn School of Medicine and Connecticut Children's presented his groundbreaking, one-year clinical trial results for the novel gene therapy treatment for glycogen storage disease.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
"The Pacific Islands are making steady progress on reducing child mortality, but most are struggling to eradicate poverty and generate employment for young and rapidly growing populations," Inter Press Service reports in an article examining how 10 of 14 nations in the region are on track to meet the Millennium Development Goal (MDG) on child mortality.
Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration caused by old age and diseases such as muscular dystrophy.
Peripheral nervous system tumors are one of the most common types of childhood tumors. While some of these tumors, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Edgar Lerma, MD 210 S Desplaines St, Chicago, IL 60661-5500 Ph: (312) 654-2700 | Juan Edgar Lerma, MD 2850 W. 95th St, Mary Potter Bldg St. 11, Evergreen Park, IL 60805-2727 Ph: (708) 499-2243 |
News Archive
At the Association for Glycogen Storage Disease's 41st Annual Conference, Dr. David Weinstein of UConn School of Medicine and Connecticut Children's presented his groundbreaking, one-year clinical trial results for the novel gene therapy treatment for glycogen storage disease.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
"The Pacific Islands are making steady progress on reducing child mortality, but most are struggling to eradicate poverty and generate employment for young and rapidly growing populations," Inter Press Service reports in an article examining how 10 of 14 nations in the region are on track to meet the Millennium Development Goal (MDG) on child mortality.
Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration caused by old age and diseases such as muscular dystrophy.
Peripheral nervous system tumors are one of the most common types of childhood tumors. While some of these tumors, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment.
› Verified 6 days ago
Dr. Thomas Bump, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3545 W 95th St, Evergreen Park, IL 60805 Phone: 708-346-5562 Fax: 708-346-2059 | |
Dolores Dixon-grevious, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2850 W 95th St, Suite 301, Evergreen Park, IL 60805 Phone: 708-389-2200 Fax: 708-389-6686 | |
Vinitha Raghavan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3358 W 95th St, Evergreen Park, IL 60805 Phone: 708-952-3040 Fax: 708-952-3043 | |
Wassim Ballany, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3545 W 95th St, Evergreen Park, IL 60805 Phone: 708-346-5562 | |
Dr. George Sousanieh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9125 S Pulaski Rd, Evergreen Park, IL 60805 Phone: 708-422-7715 | |
Dr. John H Burke, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3545 W 95th St, Evergreen Park, IL 60805 Phone: 708-346-5562 Fax: 708-346-2059 | |
Dr. Richard D. Kern, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2800 W 95th St, Pulmonary Medicine Consultants, Ltd., Evergreen Park, IL 60805 Phone: 708-424-9288 |